A Seattle biotech built on University of Washington research has won a $245 million patent judgment against Guardant Health over DNA sequencing technology, with the court also ordering ongoing royalties through 2033. Read More
Faster, cheaper DNA sequencing technology has revolutionized medicine in the past ten years. The tech provides the backbone for breakthroughs… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.